Opendata, web and dolomites


HBV GenetIc and Proteomic Screen

Total Cost €


EC-Contrib. €






Project "HIPShot" data sheet

The following table provides information about the project.


Organization address
postcode: 67081

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 185˙076 €
 EC max contribution 185˙076 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-RI
 Starting year 2019
 Duration (year-month-day) from 2019-03-04   to  2021-03-03


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITE DE STRASBOURG FR (STRASBOURG) coordinator 185˙076.00


 Project objective

Hepatitis B virus (HBV) is a major global health problem resulting in progressive liver disease, including cirrhosis and hepatocellular carcinoma – the second leading cause of cancer death worldwide. Although HBV structure and genome have been characterized, key aspects of the viral life cycle remain poorly understood because of the lack of a robust HBV infectious tissue culture system. Moreover, despite the development of a safe and efficient vaccine, over 240 million people are chronically infected with HBV. Thus, the development of efficient anti-viral strategies to cure HBV infection remains a critical unmet medical need. To date, there is an important gap of knowledge in basic HBV biology that results in the lack of identified drug targets to cure chronic HBV infection. These limitations can now be overcome using a state-of-the-art HBV tissue culture model combined with technological advances in genetics and proteomics. The aim of HIPShot (Hbv genetIc and Proteomic Screen) is to use cutting-edge screening techniques in human cells to identify host factors that are essential for HBV infection and at the same time targets for antiviral cure. With my expertise in using forward genetic screening and proteomic approaches, I decided to join one of the leading groups in HBV research, lead by Prof. Thomas Baumert (TB) and based at Inserm Unit U1110 of Université de Strasbourg (UdS), to exploit novel technologies in the investigation of host-virus interaction. The proposed project will provide unmatched insights into the basic biology of HBV infection by shedding new light on cellular host factors exploited by HBV to replicate and persist in human cells. These identified host factors will constitute direct drug targets with an important therapeutic potential.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HIPSHOT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HIPSHOT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

lanloss (2020)

Landscapes of Loss: Mapping the Affective Experience of Deforestation Among Diverse Social Groups in the South American Chaco

Read More  

TxnEvoClim (2019)

Climate adaptation in Arabidopsis thaliana through evolution of transcription regulation

Read More  

UNITE (2019)

Unification Through Law: The Court of Justice of the European Union as Cultural-Moral Agent

Read More